Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

Pharma Stories, Blogs, Interviews & Press Releases

Pharma Contract Packaging & Labelling Partners: Cost, MOQ & Regulatory Fit
Pharma Contract Packaging & Labelling Partners: Cost, MOQ & Regulatory Fit

Introduction Worldwide compliance for pharmaceutical supply chains continues to grow and change, as a result the cont...

Read Full Story
API Price Trends 2026: Cost Drivers, China Dependency & Alternatives for Buyers
API Price Trends 2026: Cost Drivers, China Dependency & Alternatives for Buyers

Introduction In 2026, API pricing for global buyers will no longer be based only on manufacturing costs. Factors such...

Read Full Story
Pharmaceutical Sourcing for Latin America: A Buyer's Guide to Medicines, APIs and CDMOs (2026)
Pharmaceutical Sourcing for Latin America: A Buyer's Guide to Medicines, APIs and CDMOs (2026)

By the PharmaTradz BD Team. Updated October 2026. Latin America is not one market. A buyer working across the region dea...

Read Full Story
Global API Sourcing 2026: Best Regions, Cost Benchmarks & Supplier Validation Checklist
Global API Sourcing 2026: Best Regions, Cost Benchmarks & Supplier Validation Checklist

Introduction In the year 2026, global sourcing of active pharmaceutical ingredients (APIs) has transformed into a hig...

Read Full Story
Global Guide to Named-Patient Import Programs (2026 Edition)
Global Guide to Named-Patient Import Programs (2026 Edition)

Named-Patient Import Programs: A Global Guide for Hospitals & Procurement Teams (2026) Around the world, a large...

Read Full Story
Authenticity & Risk Management in Global Pharma Sourcing (2026)
Authenticity & Risk Management in Global Pharma Sourcing (2026)

The complexities of global pharmaceutical sourcing have never been greater. By 2026, buyers are likely to face an increa...

Read Full Story
Generic API Suppliers in India and China: How to Compare and Qualify Them (2026)
Generic API Suppliers in India and China: How to Compare and Qualify Them (2026)

Most of the world's generic APIs are made in India and China. If you buy APIs on cost, you will almost certainly end up...

Read Full Story
Navigating Regulatory Challenges in CIS & Eastern European Pharmaceutical Markets
Navigating Regulatory Challenges in CIS & Eastern European Pharmaceutical Markets

Introduction: Understanding the Regulatory Landscape Exploring pharmaceutical markets of the CIS (Commonwealth of Ind...

Read Full Story
CIS & Eastern Europe Pharmaceutical Market Trends: Key Insights for Global Pharma Buyers
CIS & Eastern Europe Pharmaceutical Market Trends: Key Insights for Global Pharma Buyers

The CIS and Eastern Europe are gradually turning into one of the world's most important markets for multinational ph...

Read Full Story
Latin America Pharmaceutical Market: A Comprehensive Guide for Global Pharma Buyers
Latin America Pharmaceutical Market: A Comprehensive Guide for Global Pharma Buyers

Introduction The Latin American pharmaceutical market is an ever-increasing sector that keeps on drawing global inves...

Read Full Story
Pharmaceutical Sourcing for Southeast Asia: A Buyer's Guide to Medicines, APIs and CDMOs (2026)
Pharmaceutical Sourcing for Southeast Asia: A Buyer's Guide to Medicines, APIs and CDMOs (2026)

By the PharmaTradz BD Team. Updated October 2026. Southeast Asia is not one market. Singapore's regulator offers short v...

Read Full Story
Top Revenue-Losing Drugs After Patent Expiry & Their API Market Potential
Top Revenue-Losing Drugs After Patent Expiry & Their API Market Potential

Introduction: Why Revenue-Loss Drugs Matter As is the case every year, a handful of highly successful drugs lose thei...

Read Full Story

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us